Overview
Chronic lymphocytic leukemia is a slow-growing cancer of the blood and bone marrow in which the body produces an excess of abnormal lymphocytes, a type of white blood cell. Because these cells do not function normally and accumulate over time, they can crowd out healthy blood cells, leading to anemia, increased susceptibility to infection, and enlargement of lymph nodes and the spleen. It is most often diagnosed in older adults, frequently progresses gradually, and is typically characterised through blood counts, immunophenotyping, and cytogenetic and molecular analysis that guide prognosis and treatment decisions. Hematology and Oncology Research publishes peer-reviewed studies spanning the biology, diagnosis, and management of blood cancers and related malignancies, including investigations of leukemogenesis, chromosomal and molecular abnormalities in leukemias and lymphomas, and treatment outcomes in haematological cancers. Such work contributes to understanding the cellular and genetic mechanisms underlying lymphoid malignancies and the strategies used to treat them. This page gathers peer-reviewed, open-access research relevant to chronic lymphocytic leukemia and the wider field of leukemia and lymphoma biology and care.
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 4 articles above have been cited 17 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Biomolecules
-
2023 · Expert Opinion on Drug Discovery
-
2022 · Expert Opinion on Drug Discovery
-
2022 · ecancermedicalscience
-
J. Adomako et al. · 2022 · ecancermedicalscience
-
I. V. Chernikov et al. · 2021 · Russian journal of bioorganic chemistry
-
2021 · Russian Journal of Bioorganic Chemistry
-
I. Akpan et al. · 2021 ·
A sample of recent works citing this journal's research on Chronic Lymphoblastic Leukemia, linking to each citing work.